P2X7 inhibitors were in clinical phase II trials in the treatment of some autoimmune diseases [189, 190], so it would be important to further investigate the role of P2X7 during pregnancy and its potential external modulation during this critical period. This evidence concerns the gene P2RX7 and autoimmune disease.